Objective: This case-control study aimed to determine whether the imbalance in Charcot-Marie-Tooth (CMT) disease is caused only by reduced proprioceptive input or whether the involvement of the vestibular nerve is an additional factor.
In patients with Charcot-Marie-Tooth (CMT) disease, it is generally assumed that proprioceptive sensory loss causes sensory ataxia leading to postural instability. However, vestibular impairment could also contribute to the imbalance. In fact, involvement of the vestibular nerve in the polyneuropathic process has been shown to occur frequently in patients with noninherited polyneuropathy, [1] [2] [3] [4] and, interestingly, sensory neuropathy seems to be an integral part of the just recently characterized syndrome of cerebellar ataxia with bilateral vestibulopathy. 5 In inherited neuropathy, vestibular hypofunction has been, so far, documented only in single case reports, including the description of bilateral vestibular loss in 2 patients with Dejerine-Sottas syndrome 6 and of vestibular neuropathy in a Roma family with hereditary motor and sensory peripheral neuropathy due to mutations on chromosome 8p24. 7 Given the evidence that vestibular rehabilitation improves postural stability in patients with vestibulopathy, 8 identifying a concomitant vestibular impairment is clinically important.
In the current study, we set out to determine the frequency of vestibular impairment in patients with CMT disease. By assessing vestibular semicircular canal and otolith function, we further aimed to detect specific patterns of vestibular deficits.
METHODS Standard protocol approvals and patient consents. Informed consent was obtained from all participants after a full explanation of the experimental procedure. The protocol was approved by a local ethics committee and was in accordance with the ethical standards of the 1964 Declaration of Helsinki for research involving human subjects.
Study cohort and eligibility criteria. Participants of this casecontrol study were selected for eligibility from patients referred to our tertiary neurologic center for further evaluation of neuropathic symptoms between March 2009 and March 2010. Inclusion criteria were clinically affected status defined as muscle weakness of at least the foot dorsiflexors. Exclusion criteria were other known disease or medication that might cause neuropathy, reluctance to undergo nerve conduction studies, and low compound muscle action potential amplitude of the abductor pollicis brevis muscle (negative peak ,0.5 mV) hindering proper determination of the motor nerve conduction velocity of the median nerve.
Procedure. Detailed history-taking and complete neurologic examination were performed. Patients were specifically assessed for spontaneous and gaze-evoked nystagmus, correcting saccades following Halmagyi-Curthoys head impulses, 9 positional and positioning nystagmus, muscle atrophy, weakness, weak or absent tendon reflex, as well as stand, gait, and limb ataxia. Sensory examinations included touch, pain, temperature, vibration, and position sense. Vibration sense was tested with a 128-Hz tuning fork at the ankles, knees, and index fingers and considered reduced at #4/8. 10 All patients were examined by 1 of 4 authors (A. Poretti, A. Palla, H.H.J., J.A.P.). Data about the genotype were collected in all but 1 patient (patient 15), in whom family history was positive for CMT type 1A.
All patients underwent electrophysiologic investigations. Investigations were performed by 1 of 2 authors (A.A.T, J.A.P.) and supervised by 2 senior authors (K.P.W, H.H.J.). Standard nerve conduction studies (motor and sensory) included the median, ulnar, and peroneal nerves on one side (if the severity of the neurologic impairments was asymmetric, the investigation was performed on the more affected side). Age-related normative values were taken from Ludin. 11 CMT neuropathies were subdivided into 1) a predominant demyelinating form characterized by nerve conduction velocities ,38 m/s in upper-limb motor nerves, and 2) a primary axonal form with nerve conduction velocities .38 m/s in upperlimb motor nerves (subdivision according to references 12214).
Vestibular function was characterized by cervical vestibularevoked myogenic potentials (cVEMPs) for otolith function assessment and the quantitative head-impulse test (qHIT) for semicircular canal function assessment. cVEMPs were registered from contracted sternocleidomastoid muscles (SCMs). Air-conducted sound stimuli for cVEMPs (500-Hz, 6-millisecond tone bursts at 90-100 dB normal hearing level, total of 200 bursts) were presented through calibrated headphones (Telephonics TDH-39P; Telephonics Corp., Farmingdale, NY) monaurally to the right and left ears. During stimulation, subjects were asked to sit and turn their head as much as possible to the side to tense their SCM. EMG activity was recorded (Viking V system; Nicolet Biomedical, Madison, WI) from the upper half of the SCM with a reference electrode on the upper sternum. The background SCM contraction was monitored online and measured over the 20-millisecond prestimulus interval (using root-mean-square EMG). Signals of 200 air-conducted cVEMP stimuli were averaged. The resultant response consisted of an initial positive peak (p13) and a subsequent negative peak (n23). For each ear, p13-n23 amplitudes and p13 and n23 latencies were calculated. Because of the large interindividual variability in cVEMP amplitudes (ranging from 2 to 181 mV), side-to-side differences in uncorrected reflex amplitudes were expressed as asymmetry ratio (AR) calculated as 15 :
where A l is the larger and A s is the smaller amplitude obtained from stimulating each ear. 16 Subjects with bilaterally absent responses were not included in the calculation of AR. The upper normal limit of AR was set to 46% (value for uncorrected background EMG) as suggested by Welgampola and Colebatch. 16 Eighteen age-matched, healthy subjects (45 6 15 years, range 25-67 years) served as controls. The average AR value in our healthy control group (26% 6 15%, range 5%-60%) was comparable to that of Welgampola and Colebatch 16 (23%). The p13-and n23-latency values were 15.5 6 1.9 milliseconds and 25.5 6 1.3 milliseconds (average 6 1 SD), respectively. Average 6 2 SDs were defined as the upper limit of the normal range, i.e., p13 5 19.3 milliseconds and n23 5 28.1 milliseconds. For qHIT, eye and head movements were recorded in a magnetic frame (Remmel type system, modified by A. Lasker, Baltimore, MD) using search-coils, which were calibrated before each session. 17 Horizontal head impulses (amplitude: 20°-30°; duration: 150-200 milliseconds; peak velocity: about 300°/s; peak acceleration: about 10,000°/s 2 ) were applied by an investigator standing behind the subject who was visually fixing upon a target light 1.24 m straight ahead. The directions of the head impulses were pseudorandomly intermingled, and 4 to 6 impulses were performed in each direction. The gain of the horizontal semicircular-ocular reflex was determined by computing the coefficient eye-in-head displacement divided by head-in-space displacement as head-in-space moved from 3°to 7°e ccentricity from straight ahead. 18 As the representative gain during head impulses to either side, the median value was computed.
Median gain values were considered pathologic if they were ,2 SDs of the average gain determined in healthy controls. This healthy control group consisted of 12 healthy subjects (6 women; 43 6 10 years) selected by age frequency matching from a previously published population of 28 healthy subjects (15 women; 18-75 years, 44 6 15 years). 19 All patients underwent routine pure tone audiometry to ascertain the absence of conductive hearing loss. Hearing was normal in 9 patients, whereas sensorineural hearing loss comprising the midfrequency (.0.5 to #2 kHz) to high-frequency (.2 to #8 kHz) range was present in the remaining 6 patients (frequency range definition according to Stephens, 20 2001 ). The sensorineural hearing loss affected both ears symmetrically in 5 patients and was accentuated in the right ear in 1 patient.
Statistical analysis. Statistical analysis was performed using MATLAB version 7.5 (The MathWorks, Natick, MA). Unpaired 2-tailed t test was used for average analysis and the Wilcoxon rank sum test was used for CMT subclassification analyses. Principal component analysis was used for correlation analyses between vestibular and peripheral nerve conduction parameters, because principal component analysis is more appropriate than standard linear regression analysis for dependent, i.e., intercorrelated, variables. 21 For correlation analyses with age (independent variable) and vestibular and nerve conduction data, respectively, robust linear regression analysis (robustfit.m) was used. A level of significance of 0.05 was adopted and 95% confidence intervals (CIs) were calculated.
RESULTS
At the time of the study, the median age of patients (n 5 15; 8 women) was 48 (617) years (range 23-74 years). Abnormal clinical findings included the following: 1) unilateral (n 5 5) or bilateral (n 5 2) abnormal bedside head-impulse test; 2) stand and gait ataxia (n 5 11); and 3) sensory deficits (touch: n 5 6; pain: n 5 3; temperature: n 5 3; position: n 5 6; vibration: n 5 8), muscle atrophy (n 5 12), muscle weakness (n 5 13), weak or absent tendon reflexes (n 5 13), and pes cavus (n 5 5).
CMT phenotypes included CMT1, CMTX, CMT2, CMT4, and intermediate (DI) CMT (details are summarized in the table). Five patients could not be classified. The genotype included duplication in the peripheral myelin protein 22 (PMP22) gene, mutation in the gap junction B1 (GJB1) gene (connexin 32), and point mutation in the myelin protein zero (MPZ) gene. Six patients (1 patient with CMT2, 1 patient with CMT4, and 4 patients with unclassified CMT) remained genetically undefined, whereby mutations in the PMP22, GJB1, MPZ, and mitofusin 2 genes were excluded. Family history was positive in all 6 patients. Genetic testing was not performed in 1 patient (patient 15 in the table), but family history was positive for CMT type 1A.
On the basis of nerve conduction studies and the genotype, patients were classified into a primary demyelinating group (n 5 13) or a primary axonal group (n 5 2, patients 5 and 10 in the table). Average age between demyelinating (47 6 13 years) and axonal (46 6 15 years) patients was not different (unpaired 2tailed t test, p . 0.8).
The cVEMPs were registered in 14 patients. Because of a technical defect, 1 patient (ID 6) was not tested by cVEMP. In 12 patients, cVEMPs were detectable from both SCMs, in 1 patient (ID 9) from 1 SCM side only, and in 1 patient (ID 4) cVEMPs were bilaterally absent. For further comparison, the 74-yearold patient (ID 4) with bilaterally absent responses was excluded because cVEMPs can also be absent in healthy subjects older than age 60. 22 The remaining 13 patients included in further analysis were all younger than 62 years ( figure 1B) . Figure 2 shows examples of cVEMP traces (averaged over 200 repetitions) recorded from the left (A) and right (B) SCM in 1 healthy subject (black line) and 1 patient (red line). In the patient (ID 13), uncorrected, averaged, raw peak-to-peak amplitudes were within the normal range of healthy subjects whereas p13 and n23 latencies were prolonged in responses to clicks delivered on the left ear (dashed vertical lines depict upper limit of normal p13 and n23 latencies; for values, see the Methods section).
Averaged, uncorrected, raw peak-to-peak amplitudes (61 SD) in all patients (i.e., 26 ears) were 91 6 101 mV ( figure 1A ). Average AR (61 SD) of uncorrected amplitudes was 35% 6 26% ( figure 1B) . Although average AR was within the normal range (37% 6 26%; unpaired 2-tailed t test, p . 0.2; cutoff of upper normal limit set to 46% according to were prolonged in both ears. CMT subgroup analyses showed no differences for cVEMP ARs and p13 and n23 latencies (Kruskal-Wallis, p . 0.2). Additionally, no differences were found between predominant demyelinating (n 5 10; AR: 35% 6 30%; p13: 19 6 2 milliseconds; n23: 27 6 2 milliseconds) and predominant axonal neuropathies (n 5 2; AR: 50% 6 5%; p13: 18 6 0.6 milliseconds; n23: 27 6 0.9 milliseconds; unpaired 2-tailed t test, p . 0.1). We emphasize, however, that subgroup analyses must be evaluated with caution because of the small number of patients participating in this study. Compared with healthy subjects, the average gain of the high-acceleration horizontal vestibulo-ocular reflex, as determined by the qHIT, was reduced in patients with CMT disease (figure 3; average gain 6 1 SD of pooled ears from healthy subjects: 0.86 6 0.07; pooled ears from patients: 0.67 6 0.24; paired t test, p , 0.001; symbols as in figure 1 ). Overall, 9 of 15 patients showed deficient gain values in one direction (CMT1A, n 5 1; CMTX, n 5 1; undefined CMT, n 5 2) or both directions (CMT1A, n 5 1; CMT2, n 5 1; CMT4D, n 5 1; DI-CMT, n 5 1; undefined CMT, n 5 1), whereas gain values to both sides were normal in 6 patients. As for cVEMPs, average gain values during qHIT to either side were not different among CMT subgroups (Kruskal-Wallis, p . 0.1) and between primary demyelinating (0.67 6 0.2) and primary axonal neuropathies (0.67 6 0.04; unpaired 2-tailed t test, p . 0.1). Again, we emphasize that because of the small number of patients in the respective subgroups this finding can only be preliminary.
In summary, we found that vestibular function was impaired in the majority, i.e., in 14 of 15, of our patients with CMT disease. In 8 of 13 patients (for comparison of otolith and semicircular canal function, only patients with both elicitable cVEMPs and qHIT were taken), both otolith and semicircular canal functions were impaired, and the side of otolith and semicircular canal impairment (i.e., the affected ear) correlated in 6 patients. Interestingly, "isolated" otolith impairment, as determined by increased AR and/or prolonged p13-n23 cVEMP latencies, occurred more frequently (4/13 patients) than "isolated" semicircular canal deficiency (1/13 patients), as assessed by qHIT. Moreover, all patients with semicircular canal impairment also evidenced otolith abnormalities, whereas the reverse was not true.
Vestibular function was further compared with peripheral nerve conduction parameters (table) . Regression analyses demonstrated moderate correlation between cVEMP p13 latencies and median nerve conduction velocities (principal component analysis; R 2 5 0.17, slope 5 24.0, 95% CI 5 247.3 to 22.1), between cVEMP p13 latencies and peroneal nerve distal motor latencies (principal component analysis; R 2 5 0.28, slope 5 1.7, 95% CI 5 1.3-9.2), and between cVEMP amplitudes and ulnar nerve distal motor latencies (principal component analysis; R 2 5 0.3, slope 5 0.02, 95% CI 5 0.02-0.05). All other correlation analyses between vestibular and peripheral neuropathy data as well as correlation analyses (regression analysis) between age and electrophysiologic data were nonsignificant. Thus, although the first 2 findings point toward a positive link between the degree of vestibular impairment and peripheral neuropathy deficiency, these results, in particular also considering the moderate significance and the inverse correlation between cVEMP amplitudes and ulnar nerve distal motor latencies, should be interpreted with caution because of the small patient sample size. DISCUSSION This study demonstrates the high prevalence of coexisting vestibular and peripheral neuropathy in a group of patients affected by CMT disease. Vestibular impairment was present in the majority of patients with CMT disease, irrespective of their clinical phenotype and their genotype. Interestingly, cVEMPs were more frequently impaired than the qHIT, suggesting that the former might have a higher sensitivity in detecting vestibular, specifically otolith, impairment than the latter.
Our results are in line with previous findings in a more heterogeneous population of patients with polyneuropathy, where we recently identified that postural imbalance was a multisensory balance disorder due to a concomitant vestibular and proprioceptive impairment, rather than due to an isolated proprioceptive sensory loss. 3 Characterizing patients with vertigo and/or dizziness requires information concerning the function of the vestibular end-organs as a whole. Although it is known from single case reports that semicircular canal function can be involved in inherited neuropathies, 6, 7 to our knowledge, this is the first study characterizing otolith function. cVEMPs were investigated in this study, as vestibulospinal pathways are important structures when evaluating balance control.
Air-conducted sound stimuli used to induce cVEMPs activate vestibular afferent neurons predominantly originating from the saccular macula that project via vestibulospinal pathways to the neck muscles, specifically to the motor neurons of the ipsilateral SCM. A lesion anywhere in these pathways can result in abnormal cVEMPs. In our study, we found that cVEMP latency was affected more often than cVEMP amplitude. This pattern is analogous to other pathologies affecting the primary vestibular nerve or central vestibular pathways, such as multiple sclerosis, vestibular schwannoma, and inferior vestibular neuritis, 23, 24 and explained by a reduction in conduction velocity along the nerve fibers. 25 In fact, the majority of our patients had demyelinating neuropathy, which results in slow nerve conduction velocities. In contrast, other primary vestibular end-organ disorders, e.g., Ménière disease, 26 predominantly show reduced cVEMP amplitudes whereas latencies are relatively preserved (see Welgampola and Colebatch 15 [2005] for review).
When comparing results from cVEMPs with qHIT, our study suggests that cVEMPs may be more sensitive for detecting vestibular involvement in patients with CMT disease. In fact, besides the higher proportion of cVEMP compared with qHIT abnormalities found in our patients, we also observed that reduced qHIT was always associated with cVEMP abnormalities whereas the reverse was not true. This suggests that cVEMPs may be particularly useful for detecting early stages of vestibular impairment. Presumably, differences between cVEMP and qHIT sensitivity arise from prolonged latencies appearing earlier due to the polysynaptic pathway activation in cVEMPs vs the oligosynaptic pathways stimulated by qHIT.
The small number of patients and the heterogeneous phenotype are of course limitations of this study, and comparison of vestibular function among different CMT genotypes was not reliably possible. The high percentage of vestibular impairment found in our small cohort nevertheless emphasizes the importance of routinely investigating vestibular function in patients with CMT disease, ideally by cVEMPs. Fortunately, technical advancements within the last few years have made laboratory HIT 27 and cVEMP 28 assessments easily accessible and have paved the way for exploring their clinical applicability, in particular regarding patients' symptoms, which, to date, remain a major unresolved issue. 29 However, recognizing a combination of vestibular impairment and peripheral neuropathy is in fact highly relevant because physical therapy should then focus on vestibular exercises, which have been shown to enhance vestibular function and improve compensatory sensory strategies, in particular vision. 30 
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Figure 3
Gains of the horizontal vestibulo-ocular reflex during head impulses to both sides in patients and healthy controls
Gains of the horizontal vestibulo-ocular reflex during head impulses to both sides in patients and healthy controls. Mean and 95% confidence interval over all healthy subjects (filled square on the left) and all patients (filled circle on the right) are depicted. Patients' subgroups (symbols as in figure 1 ) are shown on the right. Horizontal dashed line: lower gain limits of healthy subjects (average 6 2 SDs). CMT 5 Charcot-Marie-Tooth.
